CSIMarket
 


Nucana Plc  (NCNA)
Other Ticker:  
 

Cumulative Nucana Plc's Quick Ratio for Trailing Twelve Months Period

NCNA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

NCNA Quick Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Growth 64.82 % 64.82 % 64.82 % 64.82 % 43.77 %
Y / Y Cash & cash equivalent Growth -28.42 % -28.42 % -28.42 % -28.42 % -30.59 %
Quick Ratio for Trailing Twelve Months Period 2.5 3.05 3.73 4.6 5.76
Total Ranking # 1172 # 1066 # 1074 # 958 # 787
Seq. Current Liabilities Growth 0 % 0 % 0 % 64.82 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % -28.42 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $19 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 2.5 below Nucana Plc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 360 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Nucana Plc. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about NCNA
Quick Ratio NCNA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 361
Sector # 635
S&P 500 # 1151


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
14.6 8.96 2.5
(Dec 31 2018)   (Dec 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Applied Molecular Transport Inc   6.83 
Neximmune Inc   6.68 
Frequency Therapeutics Inc   6.66 
Nighthawk Biosciences inc   6.64 
Glycomimetics Inc   6.61 
Biovie Inc   6.60 
Blue Water Biotech Inc   6.59 
Gossamer Bio Inc   6.56 
Repare Therapeutics Inc   6.52 
Zynerba Pharmaceuticals Inc   6.52 
Evoke Pharma Inc   6.49 
Dermata Therapeutics Inc   6.48 
Scynexis Inc   6.39 
Ampio Pharmaceuticals inc   6.38 
Theriva Biologics inc   6.29 
Virios Therapeutics Inc   6.28 
Corcept Therapeutics Inc  6.27 
Ngm Biopharmaceuticals Inc   6.26 
Foghorn Therapeutics Inc   6.26 
Mei Pharma Inc   6.22 
Catalyst Pharmaceuticals Inc   6.20 
Verona Pharma Plc  6.17 
Concert Pharmaceuticals Inc   6.16 
Abcellera Biologics Inc   6.02 
Albireo Pharma inc   5.99 
Summit Therapeutics Inc   5.97 
Scpharmaceuticals Inc   5.89 
Trevi Therapeutics Inc   5.83 
Cue Biopharma Inc   5.82 
Maravai Lifesciences Holdings Inc   5.82 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com